OMIX007047

1Summary
Title Metabolomic profiling of MC38 treated by eliglustat
Description A lipidomic analysis was performed to determine the effect of the commercially available UGCG inhibitor eliglustat on lipid metabolism and expression.
Organism Mus
Data Type Lipidome Data by Mass Spectrometry (MS)
Data Accessibility Open-access
BioProject PRJCA026202
Release Date 2024-08-06
Submitter Weidong Han (hanwdrsw@163.com)
Organization the First Medical Center, Chinese PLA General Hospital
Submission Date 2024-07-31
2Files & Download

HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).

File ID File Title Number/Samples File Type File Size File Suffix Download
OMIX007047-01 N-MC-38-Eliglustat-3 1 Lipidome Data by Mass Spectrometry (MS) 282.84 MB raw
OMIX007047-02 P-MC-38-Eliglustat-3 1 Lipidome Data by Mass Spectrometry (MS) 196.92 MB raw
OMIX007047-03 N-MC-38-Control-3 1 Lipidome Data by Mass Spectrometry (MS) 292.69 MB raw
OMIX007047-04 P-MC-38-Eliglustat-2 1 Lipidome Data by Mass Spectrometry (MS) 208.34 MB raw
OMIX007047-05 P-MC-38-Control-2 1 Lipidome Data by Mass Spectrometry (MS) 181.12 MB raw
OMIX007047-06 P-MC-38-Control-3 1 Lipidome Data by Mass Spectrometry (MS) 202.57 MB raw
OMIX007047-07 N-MC-38-Eliglustat-1 1 Lipidome Data by Mass Spectrometry (MS) 296.62 MB raw
OMIX007047-08 N-MC-38-Control-1 1 Lipidome Data by Mass Spectrometry (MS) 292.71 MB raw
OMIX007047-09 N-MC-38-Control-2 1 Lipidome Data by Mass Spectrometry (MS) 259.03 MB raw
OMIX007047-10 P-MC-38-Eliglustat-1 1 Lipidome Data by Mass Spectrometry (MS) 204.07 MB raw
OMIX007047-11 N-MC-38-Eliglustat-2 1 Lipidome Data by Mass Spectrometry (MS) 288.87 MB raw
OMIX007047-12 P-MC-38-Control-1 1 Lipidome Data by Mass Spectrometry (MS) 167.25 MB raw
3Relevant Publications
Paper Title Journal Name Publish Time Accession Citing Type
Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I … Nature Communications 2024-08 OMIX007047 Deposit

View All Released Data of OMIX